Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (

G. Cancello, P. Maisonneuve, N. Rotmensz, G. Viale, M. G. Mastropasqua, G. Pruneri, P. Veronesi, R. Torrisi, E. Montagna, A. Luini, M. Intra, O. Gentilini, R. Ghisini, A. Goldhirsch, M. Colleoni

Research output: Contribution to journalArticlepeer-review

Abstract

Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients

Original languageEnglish
Pages (from-to)1974-1981
Number of pages8
JournalAnnals of Oncology
Volume21
Issue number10
DOIs
Publication statusPublished - Mar 23 2010

Keywords

  • Adjuvant therapy
  • Breast cancer
  • Prognostic features
  • Very young women

ASJC Scopus subject areas

  • Oncology
  • Hematology

Fingerprint Dive into the research topics of 'Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women ('. Together they form a unique fingerprint.

Cite this